Heart Disease Trial, Recruiting NCT07550790 Sponsor: Seoul National University Bundang Hospital Condition: Heart Disease
Back to Heart Disease

Heart Disease Trial, Recruiting

NCT07550790
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • Adults aged 20 years or older
  • People who visited an emergency department or were admitted to hospital for sudden (acute) heart failure, with signs of fluid build-up in the body
  • People who are already planned to have a contrast-enhanced CT scan (a type of detailed X-ray using a special dye) during the same hospital stay
  • People who have mild to moderate kidney problems, based on a specific kidney function measurement (eGFR between 30 and 75 mL/min/1.73 m²) — this is a blood test result that estimates how well the kidneys are filtering (confirm with trial site)

Who may not be able to join:

  • People who need medications to keep their blood pressure up (vasopressors)
  • People who need dialysis or any other form of kidney replacement treatment
  • People who have a known allergy or bad reaction to the water pill furosemide (also known as Lasix)
  • People who are currently experiencing an active heart attack or related heart emergency (acute coronary syndrome)
  • Women who are pregnant, breastfeeding, or who could become pregnant and do not have a negative pregnancy test result
  • People with potassium levels in the blood that are too high (above 5.5 mmol/L)
  • People who are significantly dehydrated or have sodium (salt) levels in the blood that are too low (below 130 mmol/L)
  • People whose overall health situation is considered by the trial doctor to make joining the trial unsuitable

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 9 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Jin Joo Park, MD, PhD, Seoul National University Bundang Hospital

Phone: +82-031-787-8800

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Seoul National University Bundang Hospital
Registry
ClinicalTrials.gov
Start date
1 May 2026
Est. completion
30 January 2029

Where this trial is recruiting

🇰🇷 South Korea

Primary endpoints

Incidence of contrast-induced acute kidney injury

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 9 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov